Since the Feb. 18 announcement that Actavis would acquire Forest Laboratories for about $25 billion, which caused Forest Laboratories stock to leap higher, Mylan stock has been moving up strongly in sympathy on speculation it, too, could be bought. However, the Smart Money has been selling Mylan into the strength, and with
This post was just published on ZYX Short Change Alert. FRX is being held from an average price of $72.88. Take profits and exit the position. FRX is trading around $64 in the pre market as of this writing.
This post was just published on ZYX Short Change Alert. Those who took advantage of the pre-market spike on January 21st when the stock traded as high as $75.30 should be holding 40% of the full core position size from an average price around $72.88. The stock is trading at $66.05
This post was just published on ZYX Short Change Alert. FRX is a pharmaceutical company that is running up in the pre-market as it buys another company. The irony is that FRX stock has been levitating in part because this company was supposed to be a buy out candidate. The acquisition